|
|||||
|
|
Lipid effects of switching from prescription EPA+DHA (omega-3-acid ethyl esters) to prescription EPA only (icosapent ethyl) in dyslipidemic patients |
|
| Authors: | James R. Crandell Christina Tartaglia Joseph Tartaglia |
| Affiliation: | 1. Private practice, Lakewood, OH, USA;2. Private practice, White Plains, NY, USA |
| Abstract: | |
| Keywords: | Docosahexaenoic acid dyslipidemia eicosapentaenoic acid LDL cholesterol omega-3 fatty acids Lovaza Vascepa |